Mimedx (MDXG) Gross Profit Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 411.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.16% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.34% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 51.16% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -11.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.11% |
| Dec 31, 2025 | 18.18% |
| Sep 30, 2025 | 19.62% |
| Jun 30, 2025 | 13.23% |
| Mar 31, 2025 | 13.53% |
| Dec 31, 2024 | 20.24% |
| Sep 30, 2024 | 9.09% |
| Jun 30, 2024 | 9.30% |
| Mar 31, 2024 | 12.53% |
| Dec 31, 2023 | 8.13% |
| Sep 30, 2023 | 7.40% |
| Jun 30, 2023 | 14.19% |
| Mar 31, 2023 | 4.65% |
| Dec 31, 2022 | -1.97% |
| Sep 30, 2022 | -9.81% |
| Jun 30, 2022 | -1.54% |
| Mar 31, 2022 | -6.10% |
| Dec 31, 2021 | -18.98% |
| Sep 30, 2021 | -12.71% |
| Jun 30, 2021 | -13.68% |
| Mar 31, 2021 | -12.37% |
| Dec 31, 2020 | -9.72% |
| Sep 30, 2020 | -10.24% |
| Jun 30, 2020 | -14.22% |
| Mar 31, 2020 | -5.24% |
| Dec 31, 2019 | 1.56% |
| Sep 30, 2019 | 10.27% |
| Jun 30, 2019 | 4.92% |
| Mar 31, 2019 | 9.19% |
| Dec 31, 2018 | 20.60% |
| Sep 30, 2018 | 21.82% |
| Jun 30, 2018 | 28.51% |
| Mar 31, 2018 | 28.05% |
| Dec 31, 2017 | 29.68% |
| Sep 30, 2017 | 35.28% |
| Jun 30, 2017 | 46.64% |
| Mar 31, 2017 | 54.17% |
| Dec 31, 2016 | 59.87% |
| Sep 30, 2016 | 59.14% |
| Jun 30, 2016 | 64.04% |
| Mar 31, 2016 | 67.58% |
| Dec 31, 2015 | 74.48% |
| Sep 30, 2015 | 88.94% |
| Jun 30, 2015 | 120.83% |
| Mar 31, 2015 | 134.93% |
| Dec 31, 2014 | 175.56% |
| Sep 30, 2014 | 187.80% |
| Jun 30, 2014 | 176.13% |
| Mar 31, 2014 | 267.76% |